Market News
4 min read | Updated on March 13, 2025, 12:26 IST
SUMMARY
Stock market today: At 12:13 PM, the S&P BSE SENSEX was trading at 74,012.57, down 17.19 points, or 0.02%, while the NSE's NIFTY50 index was trading at 22,439.10, down 31.40 points, or 0.14%.
Stock list
In the broader market, the BSE MidCap index was trading at 39,274.85, down 89.74 points, or 0.23%. | Image: Shutterstock
At 12:13 PM, the S&P BSE SENSEX was trading at 74,012.57, down 17.19 points, or 0.02%, while the NSE's NIFTY50 index was trading at 22,439.10, down 31.40 points, or 0.14%.
In the broader market, the BSE MidCap index was trading at 39,274.85, down 89.74 points, or 0.23%, while the BSE SmallCap index was trading at 43,968.51, down 149.30 points, or 0.34%.
According to data shared by Minister of State for Communications Pemmasani Chandra Sekhar in Lok Sabha, BSNL has earned ₹2,387.82 crore and MTNL ₹2,134.61 crore up to January 2025 from monetisation of lands and buildings.
At the time of writing this article, the stock was trading 2% higher at ₹282.34 on the NSE.
Besides, the company said it would launch an open offer to buy an additional up to 26% of equity.
The stock is down 56% in one month.
Last week, the company received a refund of ₹177 crore from the Income Tax Department.
CLSA, in its latest note on the lender, said that over the next 2-3 quarters, there will be lingering uncertainty over more skeletons in the closet and management continuity. If a PSU banker is appointed, there would be even more negative sentiment for the stock.
On Tuesday, the company said that its subsidiary Jubilant Cadista Pharmaceuticals Inc., USA, (Jubilant Cadista)’s solid oral formulations facility at Salisbury, Maryland, USA (Facility) has received the Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for the said Facility with respect to the inspection conducted by the said regulatory agency in January 2025.
About The Author
Next Story